A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
Why don't we have better treatment options for people addicted to meth? It's more complicated than you would think.
Idaho feels removed from the headlines about drug overdoses that dominate coverage of coastal cities and struggling rust belt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results